Skip to main content

Profile

Loading content
 Deniz Turkmen

Deniz Turkmen

PhD researcher

 College House 

 

College House, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK

Overview

Deniz is a PhD researcher in Epidemiology and Public Health Group in University of Exeter.

She is interested in pharmacogenetics epidemiology. She aims to explore the conventional and genetic factors influencing responses to medication in later lif, using UK Biobank.

Qualifications

  • 2018 MPharm – Istanbul University/ Turkey
  • 2020 MSc Health Research Methods – University of Exeter/ UK

Links

Research

Research interests

PhD: Pharmacogenetics Epidemiology

MSc: Blood pressure as a predictor of future depression in later life 

Publications

Key publications | Publications by category | Publications by year

Publications by category


Journal articles

Pilling LC, Türkmen D, Fullalove H, Atkins JL, Delgado J, Kuo C-L, Kuchel GA, Ferrucci L, Bowden J, Masoli JAH, et al (In Press). Genetic variation in activating clopidogrel: longer-term outcomes in a large community cohort.  Abstract.
Türkmen D, Masoli JAH, Kuo C-L, Bowden J, Melzer D, Pilling LC (In Press). Statin treatment effectiveness and the <i>SLCO1B1</i>*5 reduced function genotype: long-term outcomes in women and men.  Abstract.
Türkmen D, Masoli JAH, Kuo C, Bowden J, Melzer D, Pilling LC (2022). Statin treatment effectiveness and the. <i>SLCO1B1</i>. 5 reduced function genotype: Long‐term outcomes in women and men. British Journal of Clinical Pharmacology, 88(7), 3230-3240.
Pilling LC, Turkmen D, Fullalove H, Atkins JL, Delgado J, Kuo C-L, Kuchel GA, Ferrucci L, Bowden J, Masoli JAH, et al (2021). Analysis of CYP2C19 genetic variants with ischaemic events in UK patients prescribed clopidogrel in primary care: a retrospective cohort study. BMJ OPEN, 11(12). Author URL.
Bowden J, Pilling LC, Türkmen D, Kuo C-L, Melzer D (2021). The Triangulation WIthin a STudy (TWIST) framework for causal inference within pharmacogenetic research. PLOS Genetics, 17(9), e1009783-e1009783. Abstract.

Conferences

Turkmen D, Masoli JAH, Delgado J, Kuo C-L, Bowden J, Melzer D, Pilling LC (2022). Calcium Channel Blockers: Clinical Outcome Associations with Reported Pharmacogenetics Variants in 32,000 Patients.  Author URL.

Publications by year


In Press

Türkmen D, Masoli JAH, Delgado J, Kuo C-L, Bowden J, Melzer D, Pilling LC (In Press). Calcium Channel Blockers: clinical outcome associations with reported pharmacogenetics variants in 32,000 patients.  Abstract.
Pilling LC, Türkmen D, Fullalove H, Atkins JL, Delgado J, Kuo C-L, Kuchel GA, Ferrucci L, Bowden J, Masoli JAH, et al (In Press). Genetic variation in activating clopidogrel: longer-term outcomes in a large community cohort.  Abstract.
Türkmen D, Masoli JAH, Kuo C-L, Bowden J, Melzer D, Pilling LC (In Press). Statin treatment effectiveness and the <i>SLCO1B1</i>*5 reduced function genotype: long-term outcomes in women and men.  Abstract.

2022

Turkmen D, Masoli JAH, Delgado J, Kuo C-L, Bowden J, Melzer D, Pilling LC (2022). Calcium Channel Blockers: Clinical Outcome Associations with Reported Pharmacogenetics Variants in 32,000 Patients.  Author URL.
Türkmen D, Masoli JAH, Kuo C, Bowden J, Melzer D, Pilling LC (2022). Statin treatment effectiveness and the. <i>SLCO1B1</i>. 5 reduced function genotype: Long‐term outcomes in women and men. British Journal of Clinical Pharmacology, 88(7), 3230-3240.

2021

Pilling LC, Turkmen D, Fullalove H, Atkins JL, Delgado J, Kuo C-L, Kuchel GA, Ferrucci L, Bowden J, Masoli JAH, et al (2021). Analysis of CYP2C19 genetic variants with ischaemic events in UK patients prescribed clopidogrel in primary care: a retrospective cohort study. BMJ OPEN, 11(12). Author URL.
Bowden J, Pilling LC, Türkmen D, Kuo C-L, Melzer D (2021). The Triangulation WIthin a STudy (TWIST) framework for causal inference within pharmacogenetic research. PLOS Genetics, 17(9), e1009783-e1009783. Abstract.

Deniz_Turkmen Details from cache as at 2022-11-28 07:00:43

Refresh publications

Teaching

Supervision / Group

Back | Edit Profile